Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Vivus, Inc. (NQ: VVUS)
14.50 USD  +0.98 (+7.25%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Vivus, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Denner added as nominee to Vivus board by activist investor
Today 16:51 EDT
May 23 (Reuters) - First Manhattan Company (FMC) added some heavyweight muscle on Thursday to its bid to shake up the board of drugmaker Vivus Inc by naming former Carl Icahn top lieutenant Alex Denner... Read More
category companyNews
from Reuters: Company News
Bio-Wire Equity Surveillance – Closing Bell 5/23/2013
Today 16:23 EDT
Notable Jumps by % Gain and Mkt Cap Change Ariad Pharmaceuticals (NASDAQ: ARIA) +5.48% heads higher in reaction to ASCO abstracts and continued shift towards positive sentiment based on Iclusig sales... Read More
category CRMD , BLFS , Bio/Wire , and 5 more.
from Bio-Wire.Com
Bullish Two Hundred Day Moving Average Cross - VVUS
Today 16:21 EDT
In trading on Thursday, shares of Vivus, Inc. (VVUS) crossed above their 200 day moving average of $14.90, changing hands as high as $15.04 per share. Read More
category Stocks
from Market News Video
Vivus: Management’s Response and Updates
Today 15:12 EDT
I contacted Vivus (NASDAQ: VVUS) directly in an attempt to reach company management to ask them about 10% shareholder First Manhattan’s stance against their efforts to market QSYMIA for patients with a... Read More
category Bio/Wire , VVUS
from Bio-Wire.Com
Vivus Heats Up, Shorts Discouraged on Possible Bidding War
Today 11:49 EDT
Vivus (NASDAQ: VVUS) has been seeing relatively modest growth in QSYMIA (phentermine and topiramate ER) prescriptions since the drug launched in September 2012 under the FDA’s REMS agreement, which... Read More
category Bio/Wire , VVUS
from Bio-Wire.Com
Vivus (VVUS) Sees Upside on Icahn Connection
Today 10:44 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8365254 for the full story. Read More
from StreetInsider.com News Articles
Options Update for VIVUS (VVUS)
Today 3:00 EDT
NEW YORK (AVAFIN) -- During the last trading session, a new 90-day call record ... Read More
from AVAFIN
VIVUS, Inc. (VVUS) to Make Several Scientific Presentations in May
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8360711 for the full story. Read More
from StreetInsider.com News Articles
QVT Financial Purchase $20M of Convertible Debt Issued by VIVUS (VVUS)
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8355998 for the full story. Read More
from StreetInsider.com News Articles
Enteromedics Rallies On Confirmed Path To Possible Approval
May 20, 2013
EnteroMedics (NASDAQ: ETRM) is a company that focuses on gastrointestinal and metabolic diseases with its flagship product VBLOC®, which is a first-in-class weight loss treatment that prevents obesity... Read More
category ETRM , Bio/Wire
from Bio-Wire.Com
Earnings Look Back: Vivus Is Down 6.9% Since Reporting Quarterly Results 1 Week Ago (VVUS)
May 20, 2013
from Comtex SmarTrend® News Briefs
3 Pharmaceutical Stocks to Sell Now
May 17, 2013
 Read More
category Stocks to Sell , NASDAQ:CORT , NASDAQ:CEMP , and 1 more.
from InvestorPlace - Latest Headlines
VIVUS (VVUS) Prices $220M Convertible Debt Offering
May 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8345549 for the full story. Read More
from StreetInsider.com News Articles
VIVUS (VVUS) Launches $200M Convertible Notes Offering
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339301 for the full story. Read More
from StreetInsider.com News Articles
Vivus Downgraded Earlier by Lazard on News of Poorly Performing Treatment
May 14, 2013
Vivus (NASDAQ: VVUS ) is currently up nearly 2 percent despite being downgraded from Buy to Neutral at Lazard Capital Markets. Traders in Vivus are continuing to responding to news from Monday the... Read More
category Benzinga , Downgrades , Analyst Ratings , and 1 more.
from Latest Articles from Benzinga.com
Lazard Capital Downgrades Vivus (VVUS) to Neutral
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8333974 for the full story. Read More
from StreetInsider.com News Articles
VIVUS (VVUS) CEO Wilson Issues Shareholder Letter; Plans on Broader Qsiva Expansion
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8329644 for the full story. Read More
from StreetInsider.com News Articles
VIVUS CEO Issues Letter to Holders, Says In Discussions with Large Pharma Cos.
May 13, 2013
VIVUS, Inc. (Nasdaq: VVUS ) (the "Company") today mailed a letter to stockholders providing an update on the Company's recent progress. The full text of the letter follows. Dear Fellow Stockholder: I... Read More
category Benzinga , News , VVUS
from Latest Articles from Benzinga.com
VIVUS (VVUS) Appoints Two New Directors
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8329627 for the full story. Read More
from StreetInsider.com News Articles
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Why Does Arena's Obesity Drug Have Abuse Potential?
May 11, 2013
A cautious DEA meets a cautiously optimistic FDA Read More
category TOKYO:ESALY , NASDAQ:OREX , NASDAQ:ARNA , and 1 more.
from Forbes Real Time
3 Pharmaceutical Stocks to Sell Now
May 10, 2013
 Read More
category Stocks to Sell , NASDAQ:CORT , NASDAQ:CEMP , and 1 more.
from InvestorPlace - Latest Headlines
Brean Capital Maintains Sell of Vivus (VVUS), Notes Slower April Growth
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8317998 for the full story. Read More
from StreetInsider.com News Articles
Will The Prescription Diet Pill Market Finally Bulk Up?
May 08, 2013
Over the past 24 hours, two developments finally occurred to suggest overweight consumers will soon have an expanding choice of prescription diet pill options. First, Arena Pharmaceuticals disclosed... Read More
category NASDAQ:OREX , NASDAQ:ARNA , NASDAQ:VVUS
from Forbes Real Time
Streetinsider.com's Hot Lunchtime Reads 05/08: (DDD) (LAZ) (VCLK) (MDLZ)
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8317297 for the full story. Read More
from StreetInsider.com News Articles
Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day
May 08, 2013
DailyFinance.com : U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial production rose 1.2%, while a house price index in the... Read More
category dish , agu , bbby , and 28 more.
from DailyFinance.com
VIVUS, Inc. (VVUS) Pops as Larger Qsymia Retail Presence Expected Soon
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8317224 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 2-Vivus in talks with large pharma cos for diet drug tie-up; shares rise
May 08, 2013
* Qsymia to be available in retail pharmacies from mid-July Read More
category companyNews
from Reuters: Company News
Vivus Bullish Moving Average Crossover Alert (VVUS)
May 08, 2013
from Comtex SmarTrend® News Briefs
StreetInsider.com Pre-Open Movers 5/8: (ALXA) (LEDR) (WBMD) Higher; (FIO) (OCLR) (VCLK) Lower (more...)
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8316611 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here